Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lyketsos

Showing results (331-340 of 396) with videos related to

Pageof 40
Sort By:
Brain Injury|April 25, 2019
Loss of consciousness and altered mental state predicting depressive and post-concussive symptoms after mild traumatic brain injuryDurga Roy, Matthew E Peters, Allen Everett, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|March 29, 2011
Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression studyKatherine A Treiber, Michelle C Carlson, Chris Corcoran, et al.
JAMA|September 23, 2015
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical TrialJeffrey L Cummings, Constantine G Lyketsos, Elaine R Peskind, et al.
Neurology|November 7, 2007
Vascular factors predict rate of progression in Alzheimer diseaseM M Mielke, P B Rosenberg, J Tschanz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 4, 2008
Effects of cardiovascular medications on rate of functional decline in Alzheimer diseaseP B Rosenberg, M M Mielke, J Tschanz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 4, 2012
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer diseaseCynthia A Munro, Crystal Flynn Longmire, Lea T Drye, et al.
Alzheimer Disease and Associated Disorders|June 15, 2006
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County studyKathleen M Hayden, Peter P Zandi, Constantine G Lyketsos, et al.
Journal of Geriatric Psychiatry and Neurology|August 26, 2015
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic InfluencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
American Journal of Alzheimer'S Disease and Other Dementias|July 5, 2018
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's DiseaseYe Tao, Matthew E Peters, Lea T Drye, et al.
The American Journal of Psychiatry|May 17, 2011
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-ADCheryl L P Vigen, Wendy J Mack, Richard S E Keefe, et al.
Pageof 40

Showing results (331-340 of 396) with videos related to

Sort By:
Pageof 40
Brain Injury|April 25, 2019
Loss of consciousness and altered mental state predicting depressive and post-concussive symptoms after mild traumatic brain injuryDurga Roy, Matthew E Peters, Allen Everett, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|March 29, 2011
Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: the cache county dementia progression studyKatherine A Treiber, Michelle C Carlson, Chris Corcoran, et al.
JAMA|September 23, 2015
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical TrialJeffrey L Cummings, Constantine G Lyketsos, Elaine R Peskind, et al.
Neurology|November 7, 2007
Vascular factors predict rate of progression in Alzheimer diseaseM M Mielke, P B Rosenberg, J Tschanz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|November 4, 2008
Effects of cardiovascular medications on rate of functional decline in Alzheimer diseaseP B Rosenberg, M M Mielke, J Tschanz, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|October 4, 2012
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer diseaseCynthia A Munro, Crystal Flynn Longmire, Lea T Drye, et al.
Alzheimer Disease and Associated Disorders|June 15, 2006
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County studyKathleen M Hayden, Peter P Zandi, Constantine G Lyketsos, et al.
Journal of Geriatric Psychiatry and Neurology|August 26, 2015
Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic InfluencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.
American Journal of Alzheimer'S Disease and Other Dementias|July 5, 2018
Sex Differences in the Neuropsychiatric Symptoms of Patients With Alzheimer's DiseaseYe Tao, Matthew E Peters, Lea T Drye, et al.
The American Journal of Psychiatry|May 17, 2011
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-ADCheryl L P Vigen, Wendy J Mack, Richard S E Keefe, et al.
Pageof 40